Back to SCOTIA CAPITAL INC. SCOTIA CAPITAL INC.

EPRXEPRX
9 quarters

Position history for SCOTIA CAPITAL INC.SCOTIA CAPITAL INC.'s holdings in EUPRAXIA PHARMACEUTICALS INC

SCOTIA CAPITAL INC. holds 1.3M shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $8.8M as of 2026-Q2. The position was increased (+0.1% shares). EPRX represents 0.0% of SCOTIA CAPITAL INC.'s portfolio.

Current Value

$8.8M

Current Shares

1.3M

Total Value Change

+$5.3M

Total Shares Change

-23,325

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+0.1%
$8.8M0.0%$6.61
27
2026-Q1
Increased
1.3M
+4.3%
$7.2M0.0%$8.02
29
2025-Q4
Increased
1.3M
+0.7%
$9.6M0.0%$7.59
28
2025-Q3
Decreased
1.3M
-1.1%
$7.3M0.0%$5.75
0
2025-Q2
Decreased
1.3M
-16.8%
$7M0.0%$5.30
0
2025-Q1
Increased
1.6M
+11.6%
$5.1M0.0%$3.38
30
2024-Q4
Decreased
1.4M
-0.3%
$4.3M0.0%$3.09
0
2024-Q3
Increased
1.4M
+2.1%
$3.5M0.0%$2.63
27
2024-Q2
New
1.4M
-
$3.5M0.0%$2.58
37

Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used